Positron Corporation (POSC)
| Previous close | 1.0300 |
| Open | 1.0400 |
| Bid | 0.0000 x 0 |
| Ask | 0.0000 x 0 |
| Day's range | 0.9800 - 1.0400 |
| 52-week range | 0.8700 - 1.9700 |
| Volume | |
| Avg. volume | 3,290 |
| Market cap | 24.929M |
| Beta (5Y monthly) | 1.02 |
| PE ratio (TTM) | 0.36 |
| EPS (TTM) | 2.7900 |
| Earnings date | N/A |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | N/A |
GlobeNewswirePositron Corporation Announces Attrius® PET System Sale
Niagara Falls, NY, Nov. 24, 2023 (GLOBE NEWSWIRE) -- Positron Corporation (“Positron” or the “Company”) (OTC: POSC), a leading molecular imaging medical device company offering PET imaging systems and clinical services, is pleased to welcome a prominent cardiovascular practice in Pennsylvania as a new customer utilizing Positron’s Attrius® PET System and services. Positron will install the Attrius in the coming months concurrent with the facility’s radiopharmaceutical timeline. Positron is the o
- GlobeNewswire
Positron Corporation Announces Start of Clinical Study of Affinity PET-CT Device
Niagara Falls, NY, Sept. 08, 2023 (GLOBE NEWSWIRE) -- Positron Corporation (“Positron” or the “Company”) (OTC: POSC), a leading molecular imaging medical device company, is pleased to announce that the Company will begin its clinical study of its Affinity™ PET-CT imaging device with Ochsner Clinic Foundation in New Orleans, LA. on September 18, 2023. Positron’s clinical study/research will be guided by leading nuclear cardiologist Dr. Bober, Director of Molecular Imaging and Nuclear Cardiology a
- GlobeNewswire
Positron Corporation Orders Six Attrius® PET Systems and Components from Neusoft Positron Medical Systems
Niagara Falls, NY, July 31, 2023 (GLOBE NEWSWIRE) -- Positron Corporation (“Positron” or the “Company”) (OTC: POSC), a leading molecular imaging medical device company that manufactures, sells and services PET imaging systems and clinical services, is pleased to announce that in combination with its new Business Cooperative Partnership with Shenyang Intelligent Neuclear Medical Technology Co, a wholly owned subsidiary of Neusoft Medical Systems, Positron has agreed on terms to purchase the curre
